A structure-based virtual screening identifies a novel MDM2 antagonist in the activation of the p53 signaling and inhibition of tumor growthQing-yong Hu, Yang Cao, Tao Deng et al.|Acta Pharmacologica Sinica|2024Cited by 5
Abstract 3962: Pan-cancer spatial characterization of tertiary lymphoid structuresKyung Serk Cho, Linghua Wang, Yunhe Liu et al.|Cancer Research|2025Cited by 0